Direktorat Registrasi ObatValid

CARDIO ASPIRIN

Claim this product
BPOM Number
DKI9451600515A1
Approved
6 September 2026
Expiry
30 September 2027
Form
TABLET SALUT ENTERIK

About This Registration

CARDIO ASPIRIN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI9451600515A1. Its current registration status is Valid, with the licence valid until 30 September 2027. The product is registered to BAYER INDONESIA and manufactured by BAYER INDONESIA - INDONESIA. BPOM first approved this registration in September 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 7 September 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
newaero
Packaging
DUS, 3 BLISTER @ 10 TABLET SALUT ENTERIK
Department
Direktorat Registrasi Obat
Data Last Updated
7 September 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

ACETYLSALICYLIC ACID

Market Intelligence

Owner Portfolio
BAYER INDONESIA holds 96 BPOM registrations
Manufacturer Scale
BAYER INDONESIA - INDONESIA produces 81 registered products
Update Status
Recently updated (17 days ago)

FDA Cross-Reference

via openFDA
Generic Name
KALI MURIATICUM, KALI PHOSPHORICUM, PLANTAGO MAJOR, CACTUS GRANDIFLORUS, DIGITALIS PURPUREA, HEART (BOVINE), L-CARNITINE, L-VALINE, THYROIDINUM (SUIS), ABROTANUM (ARTEMISIA ABROTANUM), IODIUM, LECITHIN, SPIGELIA ANTHELMIA
Product Type
HUMAN OTC DRUG
Route of Administration
ORAL
Purpose
INDICATIONS: For temporary relief of nervous anxiety with tiredness, difficulty breathing at night while sleeping, coldness of hands & feet, swelling of extremities.

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1